SLU Researchers Study Meningitis Vaccine
ST. LOUIS (AP) - Saint Louis University scientists are conducting a clinical trial of a vaccine for the last remaining strain of meningitis for which no vaccine is available.
The trial is part of a national study of an investigation vaccine for meningococcal B disease. Saint Louis University is recruiting children ages 10 to 12 to evaluate the safety and effectiveness of the vaccine.
Meningococcal meningitis is a potentially life-threatening bacterial infection. Flu-like symptoms can progress rapidly, and death can occur within hours.